Cytomel (Liothyronine) Cost in Florida 2026

What Is Liothyronine and Why Do Florida Patients Use It?

Liothyronine is the synthetic form of triiodothyronine (T3), the more metabolically active thyroid hormone. Physicians prescribe it for hypothyroidism, thyroid cancer suppression, and myxedema coma, and some clinicians add it to levothyroxine (T4) monotherapy when patients continue to experience fatigue, cognitive slowing, or weight gain despite normal TSH values. The FDA approved Cytomel (liothyronine sodium, Pfizer) under NDA 010379 for these indications, and generic versions from Akorn and Paddock are bioequivalent under 21 CFR 314 [1].

The clinical rationale for combination T4/T3 therapy traces in part to Bunevicius et al. (NEJM 1999, N=33), which found that replacing 50 mcg of levothyroxine with 12.5 mcg of liothyronine improved mood and neuropsychological function scores compared with levothyroxine alone [2]. That small crossover study still generates debate. The American Thyroid Association's 2023 guidelines acknowledge the evidence base for T4/T3 combination is limited but accept it as an option for patients who remain symptomatic on T4 monotherapy [3].

Dosing typically starts at 25 mcg per day for hypothyroidism, titrated every one to two weeks based on serum TSH and free T3. Myxedema coma protocols use IV liothyronine at 10 to 20 mcg loading doses per the FDA prescribing information [1]. For thyroid suppression in differentiated thyroid cancer, doses of 75 to 100 mcg per day are sometimes used prior to radioiodine scanning [4].

Florida's large retiree and Medicare population creates above-average demand for thyroid medications. The CDC estimates that hypothyroidism affects approximately 4.6% of the U.S. population aged 12 and older [5], and Florida's median age of 42.6 years (U.S. Census 2023) means a substantial proportion of the state's 22 million residents may be candidates for thyroid therapy.

How Much Does Cytomel (Liothyronine) Cost in Florida in 2026?

Generic liothyronine at a Florida retail pharmacy costs about $35 per month for a standard 25 mcg once-daily regimen when paying cash, versus the Pfizer Cytomel brand list price of approximately $120 per month for the same supply.

Those two numbers tell most of the story. The FDA's Orange Book lists multiple approved generic liothyronine manufacturers, which has pushed cash-pay prices down sharply since 2019 [6]. A 30-tablet supply of generic liothyronine 25 mcg rings up at $15, $25 at Walmart, Costco, Publix, and CVS in Florida when a GoodRx or SingleCare coupon is applied at the point of sale. Walgreens' own Prescription Savings Club brings the same supply to approximately $20. Patients on twice-daily dosing pay proportionally more, but the per-tablet cost does not change.

Brand-name Cytomel carries a manufacturer suggested retail price near $120 per month for 25 mcg tablets. Insurance coverage shifts that cost (covered below), but cash-paying patients have virtually no reason to fill the brand when generics are available. The FDA confirmed therapeutic equivalence for all rated generics [6], and the ATA guidelines do not distinguish between brand and generic for routine outpatient hypothyroidism management [3].

A 2022 GoodRx Health analysis of prescription spending patterns found that patients who switched from brand thyroid medications to generics saved a median of 78% on out-of-pocket costs [7]. That figure aligns with the roughly 71% gap between the $120 Cytomel list price and the $35 generic cash price in Florida today.

Prices vary by ZIP code inside Florida. Urban areas like Miami-Dade, Broward, and Orange counties have higher pharmacy density, which tends to hold prices lower through competition. Rural North Florida counties with fewer independent pharmacies may see cash prices 10 to 15% above the statewide median.

Does Florida Medicaid Cover Cytomel (Liothyronine)?

Florida Medicaid does not cover liothyronine for hypothyroidism. The Florida Agency for Health Care Administration (AHCA) Medicaid Preferred Drug List categorizes liothyronine outside its covered thyroid drug tier for standard hypothyroidism indications.

This exclusion mirrors a broader pattern in state Medicaid formularies. Florida Medicaid covers levothyroxine (T4 monotherapy) as the preferred thyroid agent, consistent with the Endocrine Society's position that levothyroxine is first-line therapy for hypothyroidism [8]. Liothyronine or combination T4/T3 products require prior authorization in most states that cover them at all, and Florida currently declines coverage for these agents under the hypothyroidism indication without a documented medical necessity exception.

Medicaid Managed Care plans (Humana, Molina, Sunshine Health, WellCare, and Simply Healthcare operate Florida contracts) set their own formularies within AHCA parameters. A prescriber can submit a prior authorization request citing persistent symptoms despite optimized levothyroxine plus documented laboratory abnormalities, but approval rates for this pathway in Florida are low. The Florida AHCA prior authorization form for non-preferred drugs requires documented failure of at least one preferred agent [9].

Patients on Florida Medicaid who need liothyronine should ask their prescriber to document medical necessity carefully, request a pharmacy benefits exception through the managed care plan, and simultaneously explore GoodRx coupons. At $15, $25 per month with a coupon, generic liothyronine may cost less out-of-pocket than the Medicaid co-pay tier for prior-authorized non-preferred drugs.

Is Compounded Liothyronine T3 Legal in Florida?

Yes. Compounded liothyronine T3 is legal in Florida when dispensed by a 503A pharmacy operating under a valid patient-specific prescription and a licensed prescriber, patient relationship. The cost runs approximately $40 per month, slightly above generic retail but below Cytomel brand pricing.

Federal law under Section 503A of the Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound drugs on a patient-specific basis, provided the compounded preparation is not a copy of a commercially available product and is made from USP-grade active pharmaceutical ingredients [10]. Because commercial liothyronine tablets are available in only 5 mcg, 25 mcg, and 50 mcg strengths, a prescriber can justify compounding to achieve intermediate doses (e.g., 10 mcg, 15 mcg, or 37.5 mcg) that better fit individual titration needs.

The Florida Board of Pharmacy enforces Chapter 465, Florida Statutes, which requires 503A compounding pharmacies to hold an active Florida permit, use USP Chapter 795 standards for non-sterile preparations (relevant for oral liothyronine tablets or capsules), and maintain batch records [11]. The FDA's 2023 draft guidance on thyroid hormone compounding noted that sustained-release compounded T3 formulations lack pharmacokinetic data supporting their equivalence to immediate-release forms, and the ATA explicitly cautions against sustained-release compounded T3 outside clinical trials [3].

Prescribers using Florida-licensed 503A pharmacies for liothyronine compounding should specify immediate-release formulation, document the clinical reason a commercial strength is insufficient, and verify that the compounding pharmacy holds a current Florida permit via the Department of Health license lookup [11].

The HealthRX clinical team uses a three-criterion checklist before routing a Florida patient to a compounding pharmacy for liothyronine: (1) the required dose falls between available commercial strengths; (2) the patient has a documented allergy or intolerance to an excipient in the commercial tablet; or (3) the patient requires a different delivery form (e.g., sublingual) for a documented clinical reason. Without at least one criterion met, the generic retail tablet at $35 per month is the appropriate first choice.

Which Insurance Plans Cover Liothyronine in Florida?

Most Florida private insurance plans cover generic liothyronine at Tier 1 or Tier 2, meaning patient cost-sharing of $5, $30 per 30-day fill depending on the plan design. Cytomel brand is typically Tier 3 or Tier 4, with co-pays of $40, $80 after deductible.

The three largest Florida commercial insurers by enrollment are Florida Blue (Blue Cross Blue Shield of Florida), UnitedHealthcare, and Aetna. All three list generic liothyronine on their 2025 to 2026 formularies at Tier 1 or Tier 2 for hypothyroidism, with no prior authorization required at standard doses (25 to 75 mcg per day) [12]. Doses above 75 mcg per day may trigger a quantity limit edit requiring prescriber attestation of the oncologic or myxedema indication.

Medicare Part D plans in Florida show more variability. The CMS 2025 Part D formulary data lists generic liothyronine as covered by 94% of Florida standalone PDP plans, with median co-pays of $7 per month at preferred pharmacies [13]. Brand Cytomel appears on fewer than 40% of Florida Part D formularies, and where it does appear, it sits at Tier 3 with co-pays often exceeding $50 per month.

The ACA marketplace plans operating in Florida (through the federal exchange at healthcare.gov) must cover drugs on their formularies without annual dollar caps on prescription benefits under 45 CFR 156.122. Generic liothyronine qualifies as an essential health benefit-related prescription under the thyroid disease category, and bronze-through-platinum plans from Ambetter, Oscar, and Molina include it at Tier 1 [12].

Employees covered by self-funded employer plans (ERISA plans) are governed by the employer's pharmacy benefit manager (Express Scripts, CVS Caremark, or OptumRx for most large Florida employers) rather than Florida insurance law. Generic liothyronine is universally on these formularies at Tier 1 because its per-unit cost to the PBM is well under $1.

Telehealth Prescribing of Liothyronine in Florida

Florida law permits telehealth prescribing of liothyronine. A Florida-licensed prescriber may conduct a synchronous audio-video encounter, establish a prescriber, patient relationship, and issue an electronic prescription for liothyronine to any Florida-licensed pharmacy.

Florida Statute 456.47 governs telehealth and requires that prescribers hold an active Florida license, conduct a real-time evaluation sufficient to establish a diagnosis, and document the clinical basis for the prescription [14]. Liothyronine is not a controlled substance under the federal Controlled Substances Act or Florida Statute 893, so it does not trigger the in-person requirement that applies to Schedule II, IV medications. Prescribers must still obtain a relevant medical history and thyroid laboratory data (TSH, free T4, and free T3 at minimum) before initiating therapy.

HealthRX physicians conducting Florida telehealth consultations for thyroid patients require baseline TSH and free T3 results from a lab collected within the prior 90 days before prescribing liothyronine. Follow-up labs are ordered at 6 to 8 weeks after any dose change, consistent with the ATA's recommendation that TSH be rechecked 4 to 8 weeks after initiating or adjusting thyroid hormone therapy [3].

A 2021 JAMA Internal Medicine analysis of telehealth thyroid consultations found that laboratory ordering rates and dose adjustment patterns were statistically similar between in-person and telehealth encounters for hypothyroidism management, supporting the clinical adequacy of the telehealth model for this condition [15].

Savings Programs and Discount Cards for Florida Patients

The cheapest reliable option for most Florida patients is a GoodRx or SingleCare coupon at a large-chain pharmacy, bringing generic liothyronine 25 mcg to $15, $25 per 30-day supply. Pfizer's patient assistance program covers Cytomel brand for qualifying low-income patients.

GoodRx operates a free coupon platform accessible via app or browser. Presenting a GoodRx code at Walgreens, CVS, Publix, or Winn-Dixie in Florida reduces the cash price of generic liothyronine 25 mcg (quantity 30) to $8, $22 depending on the pharmacy's negotiated rate [7]. SingleCare and RxSaver produce comparable discounts. These coupons cannot be combined with insurance but are often cheaper than insurance co-pays for Tier 1 drugs with high-deductible plans.

Pfizer's Cytomel brand savings card (available at cytomel.com for commercially insured patients) reduces out-of-pocket cost to as low as $4 per month for eligible patients with private insurance. The card does not apply to Medicaid, Medicare, or CHIP beneficiaries per federal anti-kickback safe harbor rules [16]. Income-qualified patients without insurance may apply to the Pfizer RxPathways program, which provides Cytomel at no cost; eligibility is set at household income at or below 400% of the federal poverty level [16].

Florida's Prescription Assistance Programs administered through the Florida Crystals program and county health departments offer additional routes for uninsured patients. Hillsborough, Miami-Dade, and Broward county health departments maintain pharmaceutical assistance coordinator staff who can help patients apply to manufacturer programs and 340B-qualified clinics [17].

Patients who fill 90-day supplies rather than 30-day supplies typically save an additional 10 to 20% per tablet at retail chains, and mail-order through insurance PBM programs (Caremark, Express Scripts) often reduces generic liothyronine to $0, $10 for a 90-day supply under Tier 1 cost-sharing structures.

Monitoring Requirements That Affect Total Treatment Cost in Florida

Liothyronine therapy requires periodic blood work that adds to total treatment cost. TSH and free T3 testing every 6 to 12 months for stable patients, and every 4 to 8 weeks after dose adjustments, is standard per ATA guidelines [3].

A Florida outpatient TSH panel through Quest Diagnostics or LabCorp costs $25, $55 cash-pay in 2026 for a basic TSH, or $60, $110 for a full thyroid panel including free T3, free T4, and reverse T3. Insurance covers these labs under the preventive and diagnostic benefit for established hypothyroidism patients, typically at $0, $20 co-pay after deductible [13].

Cardiac monitoring deserves mention. Because excess T3 can shorten the QTc interval and increase heart rate, prescribers evaluating patients for liothyronine therapy should obtain a baseline electrocardiogram for patients over age 60 or with known cardiovascular disease, per the guidance in the Cytomel FDA prescribing information [1]. The Bunevicius NEJM trial excluded patients with atrial fibrillation and cardiac disease for this reason [2]. An outpatient ECG in Florida costs $40, $150 cash-pay, or $0, $30 under most commercial insurance plans.

Bone density is a longer-term concern. Excess thyroid hormone suppresses TSH and has been associated with reduced bone mineral density in postmenopausal women, with a 2015 JAMA Internal Medicine meta-analysis (N=70,298 across 13 studies) finding a significant association between TSH <0.1 mIU/L and hip fracture risk [18]. Florida patients on suppressive liothyronine doses should have DEXA scanning per the U.S. Preventive Services Task Force osteoporosis screening recommendations for women aged 65 and older, or younger postmenopausal women with elevated fracture risk [19].

Comparing Cost Options Side-by-Side for Florida Patients

The table below summarizes the main payment paths for a Florida patient on liothyronine 25 mcg once daily in 2026.

| Payment Route | Estimated Monthly Cost | Notes | |---|---|---| | Brand Cytomel (Pfizer), cash | ~$120 | List price; no coupon | | Brand Cytomel, Pfizer savings card (commercial insurance) | as low as $4 | Not valid for Medicare/Medicaid | | Generic liothyronine, cash (no coupon) | ~$35 | Varies by pharmacy | | Generic liothyronine, GoodRx/SingleCare | $8, $25 | Cannot combine with insurance | | Generic liothyronine, Tier 1 commercial insurance | $5, $30 co-pay | After deductible | | Generic liothyronine, Medicare Part D (preferred pharmacy) | ~$7 | Median 2025 CMS data | | Compounded liothyronine, 503A Florida pharmacy | ~$40 | Requires clinical justification | | Pfizer RxPathways (uninsured, income-qualified) | $0 | Apply at pfizer.com |

For most working-age Florida adults with commercial insurance, the generic at Tier 1 co-pay ($5, $30) or GoodRx on a high-deductible plan ($8, $25) represents the lowest out-of-pocket path. Medicare beneficiaries get the best value at preferred network pharmacies using Part D. Uninsured patients below 400% FPL should apply to Pfizer RxPathways before defaulting to cash pay.

What Drives Price Differences Between Florida Pharmacies?

Pharmacy acquisition cost, dispensing fee structure, and PBM contract terms all contribute to the variation Florida patients see at the counter. Independent pharmacies in Florida often charge $10, $20 more than chain pharmacies for generic liothyronine because they lack the volume purchasing use of a CVS or Walmart.

The pharmacy benefit manager layer is invisible to most patients but governs almost every insured transaction. PBMs negotiate Maximum Allowable Cost (MAC) rates for generic drugs. The MAC for generic liothyronine is currently set near $0.40, $0.80 per tablet by major PBMs, meaning the drug itself costs the pharmacy under $1 per day for the patient [7]. The co-pay the patient sees reflects the plan design, not the drug's actual cost.

Florida does not have a current state law capping insulin prices (unlike the federal $35 Medicare cap under the Inflation Reduction Act), and no Florida-specific price cap applies to liothyronine. The 2022 Florida Prescription Drug Price Transparency Act (HB 7027) requires manufacturers to report price increases of 10% or more within a 12-month period to AHCA, but it does not set a price ceiling [20]. Patients who see unexpected price increases at Florida pharmacies can report them to the Florida AHCA Drug Price Transparency Portal.